/Investor DB

Qiming Venture Partners — 2021 Investments

6 investments dated 2021 · listed companies and verified rows first · show all

Abogen Biosciences (艾博生物)abogenbio.comApr 2021

Abogen is a biotechnology company developing mRNA-based therapeutics and vaccines, including an mRNA shingles vaccine and mRNA-encoded T-cell engagers for cancer such as B-cell non-Hodgkin lymphoma.

AI & Machine LearningBiotechDeep TechHealthtech

Bo Ying(Founder, Chairman and CEO)

Co-investors5Y CapitalCoatue ManagementFuzhou Jiebao Rongan Venture CapitalSoftBank Vision FundBoyu CapitalGL Ventures+7 more

Csrbtxcsrbtx.cominSeries A · Jan 2021 · $17M

Cornerstone Robotics (康诺思腾), founded in 2019, develops, manufactures, and sells high-end surgical robots for medical centers and healthcare providers.

HealthtechMedical DevicesRobotics

Samuel Au(Founder)inAlexis Cheng(Founder)Zerui Wang(Founder)

Co-investorsAlpha JWC VenturesGaorong VenturesK2VC

Dingdong Maicai100.meFeb 2021

Dingdong Maicai is an online grocery retailer offering fresh food and groceries ordered via a mobile app, with fast delivery (as quick as 29 minutes) and no minimum order threshold.

ConsumerE-commerceFoodTechMiami Beach, US

Kim Perell(Manager)James Brennan(Manager)Liang Changlin(Founder)

Co-investorsCoatue ManagementGeneral AtlanticSoftBank Vision FundDST GlobalFortune Venture CapitalGaorong Ventures+2 more

Matrixportmatrixport.comin𝕏Aug 2021

BIT Invest, a flagship unit of BIT Group, offers investment solutions for cryptocurrency and digital asset holders, including structured products, fixed income instruments, and lending services secured by digital collateral.

Crypto & Web3Fintech

John Ge(Founder)inJihan Wu(Founder)in

Co-investorsBlockchain CoinvestorsFenbushi CapitalHash GlobalK3 VenturesParadigmStandard Crypto+10 more

Supermagsupermag.comSeries A · Nov 2021 · $8M

Supermag manufactures magnetic levitation motors, fluid transport systems, and vacuum solutions for semiconductor, biopharmaceutical, chemical, and energy industries.

Advanced ManufacturingBiotechDeep TechHardwareSemiconductorsSuzhou, CN

Umoja Biopharma, Inc.umoja-biopharma.comin𝕏Jun 2021

Umoja Biopharma develops in vivo CAR T cell cancer therapies using its VivoVec platform, which generates chimeric antigen receptor T cells directly inside a patient's body rather than through the traditional ex vivo process.

BiotechHealthtechSeattle, US

Andrew M. Scharenberg(Executive Officer, Director)Philip S. Low(Director)Andrew Scharenberg(Founder)Michael Jensen(Founder)Philip Low(Founder)Ryan Crisman(Founder)

Co-investorsMPM BioImpactDCVC BioQiming Venture Partners USASoftBank GroupColorado BioScience AssociationK2 HealthVentures+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.